Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Clin Pharm ; 40(5): 977-981, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29948742

RESUMO

Background Vancomycin therapeutic drug monitoring (TDM) is commonly performed to ensure safe and effective use of the antibiotic. Aim of Study To evaluate appropriateness of vancomycin TDM and its outcomes in Singapore General Hospital. Method A retrospective, cross-sectional study was conducted between 1 January 2014 and 28 February 2014 involving patients who received ≥ 1 dose of intravenous vancomycin with TDM. Patient demographics and relevant vancomycin TDM data were collected from medical records. Results Of 746 vancomycin troughs measured among 234 patients, 459 troughs (61.5%) were taken inappropriately, with a median time of 2.6 h (interquartile range 1.1-4.3) before the next scheduled dose. Inappropriate interpretation of vancomycin troughs resulted in 41 unnecessary dose suspensions, 24 dose changes, and 102 unchanged vancomycin doses. The cost incurred due to inappropriate interpretation and measurement after discontinuation of treatment was US$7286. No differences in rates of vancomycin related nephrotoxicity, ototoxicity, recurrent infection, development of infection secondary to vancomycin resistant microorganism and mortality were observed (p > 0.05). Conclusion This study highlighted a high incidence of inappropriate vancomycin TDM which has led to increased healthcare cost.


Assuntos
Antibacterianos/administração & dosagem , Antibacterianos/sangue , Monitoramento de Medicamentos/métodos , Centros de Atenção Terciária , Vancomicina/administração & dosagem , Vancomicina/sangue , Administração Intravenosa , Adulto , Idoso , Antibacterianos/economia , Monitoramento de Medicamentos/economia , Monitoramento de Medicamentos/normas , Humanos , Pessoa de Meia-Idade , Estudos Retrospectivos , Singapura/epidemiologia , Centros de Atenção Terciária/economia , Centros de Atenção Terciária/normas , Resultado do Tratamento , Vancomicina/economia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA